Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002486068 | SCV002791012 | uncertain significance | 3-methylcrotonyl-CoA carboxylase 1 deficiency | 2022-02-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002486068 | SCV003460227 | uncertain significance | 3-methylcrotonyl-CoA carboxylase 1 deficiency | 2021-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with alanine at codon 572 of the MCCC1 protein (p.Gly572Ala). The glycine residue is moderately conserved and there is a small physicochemical difference between glycine and alanine. This variant is present in population databases (rs182830931, ExAC 0.1%). This variant has not been reported in the literature in individuals affected with MCCC1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001280051 | SCV001467198 | uncertain significance | Methylcrotonyl-CoA carboxylase deficiency | 2020-07-30 | no assertion criteria provided | clinical testing |